As a result of such substantial reduction of LYN/SYK/BTK/AKT, we anticipated that constitutive levels of phosphorylation on these signal mediators would also be reduced in CLL cells upon AUY922 treatment. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.